tiprankstipranks
Cardiff Oncology, Inc. (DE:XE7C)
NASDAQ:XE7C
Germany Market

Cardiff Oncology (XE7C) Technical Analysis

3 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Cardiff Oncology, Inc.’s (XE7C) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Cardiff Oncology, Inc. is a Buy.
Cardiff Oncology, Inc.’s (XE7C) 20-Day exponential moving average is 1.36, while Cardiff Oncology, Inc.’s (XE7C) share price is €1.56, making it a Sell.
Cardiff Oncology, Inc.’s (XE7C) 50-Day exponential moving average is 1.41, while Cardiff Oncology, Inc.’s (XE7C) share price is €1.56, making it a Sell.

Cardiff Oncology (XE7C) Pivot Points

Jun 10, 2026, 10:55 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.25
1.25
1.25
1.25
1.25
1.25
1.25
Fibonacci
1.25
1.25
1.25
1.25
1.25
1.25
1.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cardiff Oncology (XE7C) Moving Averages

Jun 10, 2026, 10:55 PM
Period
Simple
Exponential
MA5
1.20Buy
1.25Sell
MA10
1.35Sell
1.31Sell
MA20
1.39Sell
1.36Sell
MA50
1.37Sell
1.41Sell
MA100
1.49Sell
1.53Sell
MA200
1.70Sell
1.79Sell
Cardiff Oncology, Inc.’s (XE7C) 10-Day exponential moving average is 1.31, while Cardiff Oncology, Inc.’s (XE7C) share price is €1.56, making it a Sell.
Cardiff Oncology, Inc.’s (XE7C) 100-Day exponential moving average is 1.53, while Cardiff Oncology, Inc.’s (XE7C) share price is €1.56, making it a Sell.
Cardiff Oncology, Inc.’s (XE7C) stock price is €1.56 and Cardiff Oncology, Inc.’s (XE7C) 50-day simple moving average is 1.37, creating a Sell signal.
Cardiff Oncology, Inc.’s (XE7C) stock price is €1.56 and Cardiff Oncology, Inc.’s (XE7C) 100-day simple moving average is 1.49, creating a Sell signal.
Cardiff Oncology, Inc.’s (XE7C) stock price is €1.56 and Cardiff Oncology, Inc.’s (XE7C) 200-day simple moving average is 1.70, creating a Sell signal.

Cardiff Oncology (XE7C) Technical Indicators

Jun 10, 2026, 10:55 PM
Name
Value
Implied Action
RSI (14)
44.17
Neutral
STOCH (9,6)
13.63
Buy
STOCHRSI (14)
13.48
Buy
MACD (12,26)
-0.04
Buy
ADX (14)
23.82
Neutral
Williams %R
-82.72
Buy
CCI (14)
-97.57
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
40.54
Neutral
ROC
-10.82
Sell
Cardiff Oncology, Inc.’s (XE7C) Relative Strength Index (RSI) is 44.17, creating a Neutral signal.
Cardiff Oncology, Inc.’s (XE7C) Trend Strength Indicator (ADX) is 23.82, creating a Neutral signal.
Cardiff Oncology, Inc.’s (XE7C) Commodity Channel Index (CCI) is -97.57, creating a Neutral signal.
Cardiff Oncology, Inc.’s (XE7C) Price Rate of Change (ROC) is -10.82, creating a Sell signal.

FAQ

Is XE7C a Buy, Hold, or Sell?
Based on XE7C’s technical indicators, XE7C is a Sell.
    What is XE7C’s RSI (14)?
    XE7C’s RSI (14) is 44.17, which suggests XE7C is a Neutral.
      What is XE7C’s MACD?
      XE7C’s MACD is -0.04, which suggests XE7C is a Buy.
        What is XE7C’s 5-day moving average?
        XE7C’s 5-day moving average is 1.20, which suggests XE7C is a Buy.
          What is XE7C’s 20-day moving average?
          XE7C 20-day moving average is 1.39, which suggests XE7C is a Sell.
            What is XE7C’s 50-day moving average?
            XE7C’s 50-day moving average is 1.37, which suggests XE7C is a Sell.
              What is XE7C’s 200-day moving average?
              XE7C’s 200-day moving average is 1.70, which suggests XE7C is a Sell.
                What is XE7C’s Williams % R (14)?
                XE7C’s Williams % R (14) is -82.72, which suggests XE7C is a Buy.
                  What is XE7C’s CCI (14)?
                  XE7C’s CCI (14) is -97.57, which suggests XE7C is a Neutral.
                    What is the share price of Cardiff Oncology, Inc.?